Jefferies Financial Group Inc. Summit Therapeutics Inc. Transaction History
Jefferies Financial Group Inc.
- $15.9 Billion
- Q4 2024
A detailed history of Jefferies Financial Group Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 45,001 shares of SMMT stock, worth $890,119. This represents 0.01% of its overall portfolio holdings.
Number of Shares
45,001
Previous 45,001
-0.0%
Holding current value
$890,119
Previous $803,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
232Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$483 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$231 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$156 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$130 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$111 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.98B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...